Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/2/2025

Switching from Enalapril to Perindopril for Heart Failure Management

Introduction to Dose Conversion

  • The American College of Cardiology and American Heart Association guidelines support switching from enalapril 10mg twice daily to perindopril 8mg once daily, representing an equivalent therapeutic dose for heart failure management 1, 2, 3
  • The equivalent perindopril dose of 8mg once daily is based on established dosing guidelines for heart failure, where both enalapril and perindopril represent maximum recommended doses 1, 2, 3

Dose Conversion Rationale and Evidence

  • ACC/AHA guidelines list enalapril maximum dose as 10-20mg twice daily and perindopril maximum dose as 8-16mg once daily for heart failure patients, supporting the dose conversion 1, 2, 3
  • Both medications are long-acting ACE inhibitors with proven mortality and morbidity benefits in heart failure, according to the American College of Cardiology 1, 2

Critical Safety Considerations

  • Hyperkalemia risk increases with ACE inhibitors, particularly in patients with renal impairment or those on potassium-sparing diuretics, as noted by the American College of Cardiology 1, 2
  • Worsening renal function is a concern; check creatinine within 1-2 weeks of the switch, as recommended by clinical guidelines 4
  • Do not combine two ACE inhibitors, as this significantly increases risk of hypotension, hyperkalemia, and renal dysfunction without added benefit, according to the American College of Cardiology and Praxis Medical Insights 1, 2, 4
  • History of angioedema is an absolute contraindication for perindopril; consider an ARB instead, with caution, as advised by the American College of Cardiology 1, 2, 3, 5

Expected Outcomes and Benefits

  • Cardiovascular outcomes (mortality, hospitalization) should remain protected as both drugs have equivalent evidence-based benefits in heart failure, according to the American College of Cardiology 1, 2

REFERENCES

4

Inhibidores de la Enzima Convertidora de Angiotensina (IECA) en el Tratamiento de la Hipertensión [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025